ENTRY       D10080                      Drug
NAME        Sirukumab (USAN);
            Sirukumab (genetical recombination) (JAN)
FORMULA     C6450H9926N1690O1998S46
EXACT_MASS  144497.421
MOL_WEIGHT  144586.9416
SEQUENCE    (A chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS PFAMSWVRQA PGKGLEWVAK ISPGGSWTYY
            SDTVTGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCARQL WGYYALDIWG QGTTVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (B chain)
            EIVLTQSPAT LSLSPGERAT LSCSASISVS YMYWYQQKPG QAPRLLIYDM SNLASGIPAR
            FSGSGSGTDF TLTISSLEPE DFAVYYCMQW SGYPYTFGGG TKVEIKRTVA APSVFIFPPS
            DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
            SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
            (Disulfide bridge: A22-A96, A146-A202, A222-B213, A228-A'228, A231-A'231, A263-A323, A369-A427, A'22-A'96, A'146-A'202, A'222-B'213, A'263-A'323, A'369-A'427, B23-B87, B133-B193, B'23-B'87, B'13-B'193)
  TYPE      Peptide
CLASS       Immunological agent
             DG02019  Interleukin inhibitor
REMARK      ATC code: L04AC15
EFFICACY    Antirheumatic, Anti-IL-6 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of rheumatoid arthritis
TARGET      IL6 [HSA:3569] [KO:K05405]
  PATHWAY   hsa04060(3569)  Cytokine-cytokine receptor interaction
            hsa04630(3569)  JAK-STAT signaling pathway
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AC Interleukin inhibitors
                 L04AC15 Sirukumab
                  D10080  Sirukumab (USAN)
            Drug groups [BR:br08330]
             Immunological agent
              DG02019  Interleukin inhibitor
               D10080  Sirukumab
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interleukins
                IL6
                 D10080  Sirukumab (USAN)
DBLINKS     CAS: 1194585-53-9
            PubChem: 135626800
///
